Newmarket (NEU) Misses Q2 EPS by 44c
Get Alerts NEU Hot Sheet
Price: $896.36 +0.34%
Financial Fact:
Research, development, and testing expenses: 36.72M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Research, development, and testing expenses: 36.72M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Newmarket (NYSE: NEU) reported Q2 EPS of $5.29, $0.44 worse than the analyst estimate of $5.73. Revenue for the quarter came in at $547.19 million versus the consensus estimate of $570.1 million.
For earnings history and earnings-related data on Newmarket (NEU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c
- Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share